Tirzepatide Prescribing at MOWBRAY HOUSE SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
853
Total Quantity
853
NHS Cost
£75.7K
vs National Avg
+339.2%
MOWBRAY HOUSE SURGERY prescribed 853 items of Tirzepatide over the last 12 months at a cost of £75,684 to the NHS. This is 339.2% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
29
Jul 2026
51
Jul 2026
47
Jul 2026
69
Jul 2026
65
Jul 2026
77
Jul 2026
77
Jul 2026
78
Jul 2026
96
Jul 2026
77
Jul 2026
103
Jul 2026
84
Prescribing Details
| Total Items | 853 |
|---|---|
| Total Quantity | 853 |
| Total NHS Cost | £75,684 |
| Presentations | 4 different forms |
| vs National Average | +339.2% |
Tirzepatide Prescribing Comparison
| This practice | 853 items |
|---|---|
| National average per practice | 194 items |
| Difference | +339.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.